Table 1.
Detection of HPIV and other viral pathogens among the outpatient and inpatient cohorts.
| HPIV1 | HPIV2 | HPIV3 | HPIV4 | |
|---|---|---|---|---|
| Mono-infection | 10/4/14 | 11/4/15 | 26/16/42 | 10/9/19 |
| Co-infection | 2/3/5 | 3/6/9 | 30/13/43 | 18/5/23 |
| HPIV2 | 0 | — | — | |
| HPIV3 | 0 | 0/1/1 | — | |
| HPIV4 | 0 | 0/1/1 | 9/0/9 | |
| HAdV | 1/0/1 | 0 | 5/2/7 | 1/0/1 |
| HRSV | 0 | 1/0/1 | 0/1/1 | 0 |
| HMPV | 1/0/1 | 0 | 4/1/5 | 2/1/3 |
| RV/EV | 0/1/1 | 2/3/5 | 18/7/25 | 13/3/16 |
| HCoV | 0 | 1/0/1 | 4/2/6 | 3/0/3 |
| HPeV | 0 | 0/2/2 | 1/0/1 | 0 |
| HBoV | 1/2/3 | 1/1/2 | 4/4/8 | 1/1/2 |
| Total | 12/7/19 | 14/10/24 | 56/29/85 | 28/14/42 |
Number of positives for outpatients/inpatients/total. No HPIV-positive samples tested positive for influenza A or B virus. HPIV, human parainfluenza virus; HAdV, human adenovirus; HRSV, human respiratory syncytial virus; HMPV, human metapneumovirus; RV, rhinovirus; EV, enterovirus; HCoV, human coronavirus; HPeV, human parechovirus; HBoV, human bocavirus.